CVs of the light/heavy peptides ratios calculated for each points of the calibration curve (Panel A), 120 injections across 40 biological replicates from the biobank 1 (Panel B) and 219 injections across 73 biological replicates from the biobanK 2 (Panel C).
Panel B -CVs of the light/heavy ratios calculated for AVPPNNSNAAEDDLPTVELQGVVPR peptide and AVPPNNSNAAEDDLPTVELQGLVPR peptide for individual patients of the biobank 1 (a, b). Distribution of the CVs of the light/heavy ratios for the two peptides over 40 biological replicates (c).
Panel C -CVs of the light/heavy ratios calculated for AVPPNNSNAAEDDLPTVELQGVVPR peptide and AVPPNNSNAAEDDLPTVELQGLVPR peptide for individual patients of the biobank 2 (a, b). Distribution of the CVs of the light/heavy ratios for the two peptides over 73 biological replicates (c). AVPPNNSNAAEDDLPTVELQGVVPR AVPPNNSNAAEDDLPTVELQGLVPR 2 0 0 2 0 2 2 0 8 2 8 3 2 8 7 2 9 8 3 0 5 3 0 9 3 2 8 3 9 2 3 9 3 3 9 7 4 4 2 4 7 5 5 3 4 5 4 2 5 5 1 6 6 7 6 9 4 6 9 6 7 2 8 7 3 3 7 3 4 7 4 8 7 4 9 7 5 0 7 6 1 7 6 7 7 6 8 7 7 0 7 8 3 7 8 9 8 1 7 8 2 4 8 2 8 CVs across 3 technical replicates (%) P 0 2 P 0 3 P 0 6 P 0 7 P 1 1 P 1 2 P 1 4 P 1 7 P 1 8 P 2 0 P 2 2 P 2 4 P 2 6 P 3 0 P 3 3 P 3 6 P 3 8 P 4 0 P 4 2 P 4 7 P 5 0 P 5 3 P 5 6 P 6 2 P 6 8 Geometric mean -14.81 % Lower 95% CI -12.00 % Upper 95% CI -18.26 % P 0 1 P 0 4 P 0 5 P 0 6 P 0 7 P 0 8 P 0 9 P 1 0 P 1 1 P 1 3 P 1 4 P 1 5 P 1 6 P 1 7 P 1 8 P 1 9 P 2 0 P 2 1 P 2 2 P 2 3 P 2 4 P 2 5 P 2 6 P 2 7 P 2 8 P 2 9 P 3 1 P 3 2 P 3 3 P 3 4 P 3 5 P 3 6 P 3 7 P 3 8 P 3 9 P 4 0 P 4 2 P 4 3 P 4 4 P 4 6 P 4 8 P 4 9 P 5 1 P 5 2 P 5 3 P 5 4 P 5 5 P 5 6 P 5 7 P 6 2 P 6 3 P 6 4 P 6 5 P 6 6 P 6 9 P 7 0 P 7 1 P 7 2 P 7 3 P 7 4 P 7 5 P 7 6 P 7 7 P 7 8 P 
